Cargando…
Advancing NGS quality control to enable measurement of actionable mutations in circulating tumor DNA
The primary objective of the FDA-led Sequencing and Quality Control Phase 2 (SEQC2) project is to develop standard analysis protocols and quality control metrics for use in DNA testing to enhance scientific research and precision medicine. This study reports a targeted next-generation sequencing (NG...
Autores principales: | Willey, James C., Morrison, Tom B., Austermiller, Bradley, Crawford, Erin L., Craig, Daniel J., Blomquist, Thomas M., Jones, Wendell D., Wali, Aminah, Lococo, Jennifer S., Haseley, Nathan, Richmond, Todd A., Novoradovskaya, Natalia, Kusko, Rebecca, Chen, Guangchun, Li, Quan-Zhen, Johann, Donald J., Deveson, Ira W., Mercer, Timothy R., Wu, Leihong, Xu, Joshua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017191/ https://www.ncbi.nlm.nih.gov/pubmed/35475002 http://dx.doi.org/10.1016/j.crmeth.2021.100106 |
Ejemplares similares
-
Technical advance in targeted NGS analysis enables identification of lung cancer risk-associated low frequency TP53, PIK3CA, and BRAF mutations in airway epithelial cells
por: Craig, Daniel J., et al.
Publicado: (2019) -
Ultra-deep sequencing data from a liquid biopsy proficiency study demonstrating analytic validity
por: Gong, Binsheng, et al.
Publicado: (2022) -
Deep oncopanel sequencing reveals within block position-dependent quality degradation in FFPE processed samples
por: Zhang, Yifan, et al.
Publicado: (2022) -
Chimeric synthetic reference standards enable cross-validation of positive and negative controls in SARS-CoV-2 molecular tests
por: Madala, Bindu Swapna, et al.
Publicado: (2021) -
COSMOS: cloud enabled NGS analysis
por: Souilmi, Yassine, et al.
Publicado: (2015)